{"transactions":[{"id":4631407,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2621,"kind":"person","name":"Vieira Roberto Wandenkolk","position":1,"cik":"0002150104","reported_name":"Vieira Roberto Wandenkolk","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Oncology"}}],"security":"Stock option (right to buy)","published_at":"2026-10-05T23:58:55.000Z","date":"2026-10-02","kind":"exercise","planned":true,"acquired":false,"shares":8333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Shares subject to the stock option vested and became exercisable with respect to 25% of the shares underlying the option on January 29, 2025 with the remaining shares vesting and becoming exercisable ratably on a monthly basis over a period of 36 consecutive months thereafter until fully vested and exercisable on January 29, 2028, subject to the Reporting Person's continued service."}],"balance_after":133334,"derivative":{"exercise_price":21.63,"expiration_date":"2034-02-01","underlying":"Common Stock","underlying_shares":8333},"source":{"system":"sec-edgar","filing":"0001193125-26-414688","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/2150104/000119312526414688/ownership.xml","form_type":"4"}},{"id":4631406,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2621,"kind":"person","name":"Vieira Roberto Wandenkolk","position":1,"cik":"0002150104","reported_name":"Vieira Roberto Wandenkolk","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Oncology"}}],"security":"Common Stock","published_at":"2026-10-05T23:58:55.000Z","date":"2026-10-02","kind":"sale","planned":true,"acquired":false,"shares":5147,"price":116.585,"value":600062.995,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was made pursuant to a 10b5-1 plan adopted by the Reporting Person on June 17, 2026, prior to the Reporting Person being appointed an officer of the Issuer, which was in effect at the time of this transaction."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $116.24 to $117.22 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 179 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025, 396 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 2, 2026, 634 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2026 and 138 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 1, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":3946,"source":{"system":"sec-edgar","filing":"0001193125-26-414688","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/2150104/000119312526414688/ownership.xml","form_type":"4"}},{"id":4631405,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2621,"kind":"person","name":"Vieira Roberto Wandenkolk","position":1,"cik":"0002150104","reported_name":"Vieira Roberto Wandenkolk","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Oncology"}}],"security":"Common Stock","published_at":"2026-10-05T23:58:55.000Z","date":"2026-10-02","kind":"sale","planned":true,"acquired":false,"shares":2086,"price":115.7298,"value":241412.3628,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was made pursuant to a 10b5-1 plan adopted by the Reporting Person on June 17, 2026, prior to the Reporting Person being appointed an officer of the Issuer, which was in effect at the time of this transaction."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $115.16 to $116.04 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 179 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025, 396 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 2, 2026, 634 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2026 and 138 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 1, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":9093,"source":{"system":"sec-edgar","filing":"0001193125-26-414688","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2150104/000119312526414688/ownership.xml","form_type":"4"}},{"id":4631404,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2621,"kind":"person","name":"Vieira Roberto Wandenkolk","position":1,"cik":"0002150104","reported_name":"Vieira Roberto Wandenkolk","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Oncology"}}],"security":"Common Stock","published_at":"2026-10-05T23:58:55.000Z","date":"2026-10-02","kind":"sale","planned":true,"acquired":false,"shares":1100,"price":114.5205,"value":125972.55,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was made pursuant to a 10b5-1 plan adopted by the Reporting Person on June 17, 2026, prior to the Reporting Person being appointed an officer of the Issuer, which was in effect at the time of this transaction."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $114.03 to $114.90 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 179 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025, 396 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 2, 2026, 634 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2026 and 138 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 1, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":11179,"source":{"system":"sec-edgar","filing":"0001193125-26-414688","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2150104/000119312526414688/ownership.xml","form_type":"4"}},{"id":4631403,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2621,"kind":"person","name":"Vieira Roberto Wandenkolk","position":1,"cik":"0002150104","reported_name":"Vieira Roberto Wandenkolk","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Oncology"}}],"security":"Common Stock","published_at":"2026-10-05T23:58:55.000Z","date":"2026-10-02","kind":"exercise","planned":true,"acquired":true,"shares":8333,"price":21.63,"value":180242.79,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 179 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025, 396 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 2, 2026, 634 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2026 and 138 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 1, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":12279,"source":{"system":"sec-edgar","filing":"0001193125-26-414688","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2150104/000119312526414688/ownership.xml","form_type":"4"}},{"id":4631397,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2633,"kind":"person","name":"Lyon Joseph Douglas","position":1,"cik":"0001817838","reported_name":"Lyon Joseph Douglas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock option (right to buy)","published_at":"2026-10-05T23:54:19.000Z","date":"2026-10-02","kind":"exercise","planned":true,"acquired":false,"shares":5833,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Fully exercisable."}],"balance_after":44167,"derivative":{"exercise_price":19.26,"expiration_date":"2032-02-02","underlying":"Common Stock","underlying_shares":5833},"source":{"system":"sec-edgar","filing":"0001193125-26-414684","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1817838/000119312526414684/ownership.xml","form_type":"4"}},{"id":4631396,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2633,"kind":"person","name":"Lyon Joseph Douglas","position":1,"cik":"0001817838","reported_name":"Lyon Joseph Douglas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock option (right to buy)","published_at":"2026-10-05T23:54:19.000Z","date":"2026-10-02","kind":"exercise","planned":true,"acquired":false,"shares":3357,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Fully exercisable."}],"balance_after":0,"derivative":{"exercise_price":13.56,"expiration_date":"2030-02-07","underlying":"Common Stock","underlying_shares":3357},"source":{"system":"sec-edgar","filing":"0001193125-26-414684","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1817838/000119312526414684/ownership.xml","form_type":"4"}},{"id":4631395,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2633,"kind":"person","name":"Lyon Joseph Douglas","position":1,"cik":"0001817838","reported_name":"Lyon Joseph Douglas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock option (right to buy)","published_at":"2026-10-05T23:54:19.000Z","date":"2026-10-01","kind":"exercise","planned":true,"acquired":false,"shares":810,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Fully exercisable."}],"balance_after":3357,"derivative":{"exercise_price":13.56,"expiration_date":"2030-02-07","underlying":"Common Stock","underlying_shares":810},"source":{"system":"sec-edgar","filing":"0001193125-26-414684","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1817838/000119312526414684/ownership.xml","form_type":"4"}},{"id":4631394,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2633,"kind":"person","name":"Lyon Joseph Douglas","position":1,"cik":"0001817838","reported_name":"Lyon Joseph Douglas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-10-05T23:54:19.000Z","date":"2026-10-02","kind":"sale","planned":true,"acquired":false,"shares":4744,"price":116.5407,"value":552869.0808,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was made pursuant to a 10b5-1 plan adopted by the Reporting Person on June 10, 2026 in effect at the time of this transaction."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $116.25 to $116.98 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 178 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025, 398 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 2, 2026, 537 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2026 and 130 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 1, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":5683,"source":{"system":"sec-edgar","filing":"0001193125-26-414684","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1817838/000119312526414684/ownership.xml","form_type":"4"}},{"id":4631393,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2633,"kind":"person","name":"Lyon Joseph Douglas","position":1,"cik":"0001817838","reported_name":"Lyon Joseph Douglas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-10-05T23:54:19.000Z","date":"2026-10-02","kind":"sale","planned":true,"acquired":false,"shares":4446,"price":115.697,"value":514388.862,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was made pursuant to a 10b5-1 plan adopted by the Reporting Person on June 10, 2026 in effect at the time of this transaction."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $115.23 to $116.21 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 178 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025, 398 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 2, 2026, 537 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2026 and 130 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 1, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":10427,"source":{"system":"sec-edgar","filing":"0001193125-26-414684","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1817838/000119312526414684/ownership.xml","form_type":"4"}},{"id":4631392,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2633,"kind":"person","name":"Lyon Joseph Douglas","position":1,"cik":"0001817838","reported_name":"Lyon Joseph Douglas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-10-05T23:54:19.000Z","date":"2026-10-02","kind":"exercise","planned":true,"acquired":true,"shares":5833,"price":19.26,"value":112343.58,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 178 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025, 398 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 2, 2026, 537 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2026 and 130 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 1, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":14873,"source":{"system":"sec-edgar","filing":"0001193125-26-414684","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1817838/000119312526414684/ownership.xml","form_type":"4"}},{"id":4631391,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2633,"kind":"person","name":"Lyon Joseph Douglas","position":1,"cik":"0001817838","reported_name":"Lyon Joseph Douglas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-10-05T23:54:19.000Z","date":"2026-10-02","kind":"exercise","planned":true,"acquired":true,"shares":3357,"price":13.56,"value":45520.92,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 178 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025, 398 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 2, 2026, 537 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2026 and 130 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 1, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":9040,"source":{"system":"sec-edgar","filing":"0001193125-26-414684","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1817838/000119312526414684/ownership.xml","form_type":"4"}},{"id":4631390,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2633,"kind":"person","name":"Lyon Joseph Douglas","position":1,"cik":"0001817838","reported_name":"Lyon Joseph Douglas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-10-05T23:54:19.000Z","date":"2026-10-01","kind":"sale","planned":true,"acquired":false,"shares":810,"price":115.3985,"value":93472.785,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was made pursuant to a 10b5-1 plan adopted by the Reporting Person on June 10, 2026 in effect at the time of this transaction."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $115.23 to $115.615 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 178 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025, 398 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 2, 2026, 537 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2026 and 130 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 1, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":5683,"source":{"system":"sec-edgar","filing":"0001193125-26-414684","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1817838/000119312526414684/ownership.xml","form_type":"4"}},{"id":4631389,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2633,"kind":"person","name":"Lyon Joseph Douglas","position":1,"cik":"0001817838","reported_name":"Lyon Joseph Douglas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-10-05T23:54:19.000Z","date":"2026-10-01","kind":"exercise","planned":true,"acquired":true,"shares":810,"price":13.56,"value":10983.6,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 178 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025, 398 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 2, 2026, 537 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2026 and 130 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 1, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":6493,"source":{"system":"sec-edgar","filing":"0001193125-26-414684","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1817838/000119312526414684/ownership.xml","form_type":"4"}},{"id":4631388,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2639,"kind":"person","name":"Maduck Sean","position":1,"cik":"0001698310","reported_name":"Maduck Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock option (right to buy)","published_at":"2026-10-05T23:49:24.000Z","date":"2026-10-02","kind":"exercise","planned":true,"acquired":false,"shares":24587,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F11","text":"Fully exercisable."}],"balance_after":41986,"derivative":{"exercise_price":8.27,"expiration_date":"2027-02-10","underlying":"Common Stock","underlying_shares":24587},"source":{"system":"sec-edgar","filing":"0001193125-26-414674","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1698310/000119312526414674/ownership.xml","form_type":"4"}},{"id":4631387,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2639,"kind":"person","name":"Maduck Sean","position":1,"cik":"0001698310","reported_name":"Maduck Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock option (right to buy)","published_at":"2026-10-05T23:49:24.000Z","date":"2026-10-01","kind":"exercise","planned":true,"acquired":false,"shares":413,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F11","text":"Fully exercisable."}],"balance_after":66573,"derivative":{"exercise_price":8.27,"expiration_date":"2027-02-10","underlying":"Common Stock","underlying_shares":413},"source":{"system":"sec-edgar","filing":"0001193125-26-414674","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1698310/000119312526414674/ownership.xml","form_type":"4"}},{"id":4631386,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2639,"kind":"person","name":"Maduck Sean","position":1,"cik":"0001698310","reported_name":"Maduck Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-10-05T23:49:24.000Z","date":"2026-10-02","kind":"sale","planned":true,"acquired":false,"shares":8744,"price":116.5534,"value":1019142.9296,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was made pursuant to a 10b5-1 plan adopted by the Reporting Person on December 8, 2025 in effect at the time of this transaction."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $116.39 to $117.22 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 205 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025, 454 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 2, 2026, 615 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2026 and 150 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 1, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":9938,"source":{"system":"sec-edgar","filing":"0001193125-26-414674","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1698310/000119312526414674/ownership.xml","form_type":"4"}},{"id":4631385,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2639,"kind":"person","name":"Maduck Sean","position":1,"cik":"0001698310","reported_name":"Maduck Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-10-05T23:49:24.000Z","date":"2026-10-02","kind":"sale","planned":true,"acquired":false,"shares":15843,"price":116.1233,"value":1839741.4419,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was made pursuant to a 10b5-1 plan adopted by the Reporting Person on December 8, 2025 in effect at the time of this transaction."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $115.38 to $116.36 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 205 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025, 454 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 2, 2026, 615 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2026 and 150 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 1, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":18682,"source":{"system":"sec-edgar","filing":"0001193125-26-414674","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1698310/000119312526414674/ownership.xml","form_type":"4"}},{"id":4631384,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2639,"kind":"person","name":"Maduck Sean","position":1,"cik":"0001698310","reported_name":"Maduck Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-10-05T23:49:24.000Z","date":"2026-10-02","kind":"exercise","planned":true,"acquired":true,"shares":24587,"price":8.27,"value":203334.49,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 205 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025, 454 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 2, 2026, 615 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2026 and 150 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 1, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":34525,"source":{"system":"sec-edgar","filing":"0001193125-26-414674","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1698310/000119312526414674/ownership.xml","form_type":"4"}},{"id":4631383,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2639,"kind":"person","name":"Maduck Sean","position":1,"cik":"0001698310","reported_name":"Maduck Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-10-05T23:49:24.000Z","date":"2026-10-01","kind":"sale","planned":true,"acquired":false,"shares":413,"price":115.5373,"value":47716.9049,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was made pursuant to a 10b5-1 plan adopted by the Reporting Person on December 8, 2025 in effect at the time of this transaction."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $115.30 to $115.615 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 205 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025, 454 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 2, 2026, 615 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2026 and 150 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 1, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":9938,"source":{"system":"sec-edgar","filing":"0001193125-26-414674","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1698310/000119312526414674/ownership.xml","form_type":"4"}},{"id":4631382,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2639,"kind":"person","name":"Maduck Sean","position":1,"cik":"0001698310","reported_name":"Maduck Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-10-05T23:49:24.000Z","date":"2026-10-01","kind":"exercise","planned":true,"acquired":true,"shares":413,"price":8.27,"value":3415.51,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 205 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025, 454 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 2, 2026, 615 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2026 and 150 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 1, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":10351,"source":{"system":"sec-edgar","filing":"0001193125-26-414674","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1698310/000119312526414674/ownership.xml","form_type":"4"}},{"id":4631372,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":184108,"kind":"person","name":"Gunn Justin Frederick","position":1,"cik":"0002155454","reported_name":"Gunn Justin Frederick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (right to buy)","published_at":"2026-10-05T23:44:53.000Z","date":"2026-10-01","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Exercisable ratably in equal installments on each monthly anniversary of October 1, 2026 over a four-year period subject to the Reporting Person's continued service through each vesting date."}],"balance_after":100000,"derivative":{"exercise_price":114.025,"expiration_date":"2036-10-01","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001193125-26-414667","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2155454/000119312526414667/ownership.xml","form_type":"4"}},{"id":4627644,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2634,"kind":"person","name":"Robb Gary Charles","position":1,"cik":"0001529655","reported_name":"Robb Gary Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2026-09-28T20:30:10.000Z","date":"2026-09-24","kind":"gift","planned":false,"acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Custodial Account for Child"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These shares are held by a child of the Reporting Person through a custodial account under the Uniform Transfers to Minors Act for which the Reporting Person is custodian."}],"balance_after":20571,"source":{"system":"sec-edgar","filing":"0001193125-26-405402","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1529655/000119312526405402/ownership.xml","form_type":"4"}},{"id":4627643,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2634,"kind":"person","name":"Robb Gary Charles","position":1,"cik":"0001529655","reported_name":"Robb Gary Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2026-09-28T20:30:10.000Z","date":"2026-09-24","kind":"gift","planned":false,"acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Custodial Account for Child"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held by a child of the Reporting Person through a custodial account under the Uniform Transfers to Minors Act for which the Reporting Person is custodian."}],"balance_after":20571,"source":{"system":"sec-edgar","filing":"0001193125-26-405402","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1529655/000119312526405402/ownership.xml","form_type":"4"}},{"id":4627642,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2634,"kind":"person","name":"Robb Gary Charles","position":1,"cik":"0001529655","reported_name":"Robb Gary Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2026-09-28T20:30:10.000Z","date":"2026-09-24","kind":"gift","planned":false,"acquired":false,"shares":17100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 224 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025, 499 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 2, 2026, 776 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2026 and 164 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 1, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":14056,"source":{"system":"sec-edgar","filing":"0001193125-26-405402","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1529655/000119312526405402/ownership.xml","form_type":"4"}},{"id":4622942,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2634,"kind":"person","name":"Robb Gary Charles","position":1,"cik":"0001529655","reported_name":"Robb Gary Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock option (right to buy)","published_at":"2026-09-18T23:47:51.000Z","date":"2026-09-17","kind":"exercise","planned":false,"acquired":false,"shares":17493,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Fully exercisable."}],"balance_after":182507,"derivative":{"exercise_price":8.27,"expiration_date":"2027-02-10","underlying":"Common Stock","underlying_shares":17493},"source":{"system":"sec-edgar","filing":"0001193125-26-395827","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1529655/000119312526395827/ownership.xml","form_type":"4"}},{"id":4622941,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2634,"kind":"person","name":"Robb Gary Charles","position":1,"cik":"0001529655","reported_name":"Robb Gary Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2026-09-18T23:47:51.000Z","date":"2026-09-17","kind":"exercise","planned":false,"acquired":true,"shares":17493,"price":8.27,"value":144667.11,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 224 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025, 499 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 2, 2026, 776 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2026 and 164 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 1, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":31156,"source":{"system":"sec-edgar","filing":"0001193125-26-395827","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1529655/000119312526395827/ownership.xml","form_type":"4"}},{"id":4619413,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2633,"kind":"person","name":"Lyon Joseph Douglas","position":1,"cik":"0001817838","reported_name":"Lyon Joseph Douglas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock option (right to buy)","published_at":"2026-09-16T20:30:08.000Z","date":"2026-09-14","kind":"exercise","planned":true,"acquired":false,"shares":7404,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Fully exercisable."}],"balance_after":4167,"derivative":{"exercise_price":13.56,"expiration_date":"2030-02-07","underlying":"Common Stock","underlying_shares":7404},"source":{"system":"sec-edgar","filing":"0001193125-26-393125","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1817838/000119312526393125/ownership.xml","form_type":"4"}},{"id":4619412,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2633,"kind":"person","name":"Lyon Joseph Douglas","position":1,"cik":"0001817838","reported_name":"Lyon Joseph Douglas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock option (right to buy)","published_at":"2026-09-16T20:30:08.000Z","date":"2026-09-14","kind":"exercise","planned":true,"acquired":false,"shares":2596,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Fully exercisable."}],"balance_after":0,"derivative":{"exercise_price":11.35,"expiration_date":"2029-02-08","underlying":"Common Stock","underlying_shares":2596},"source":{"system":"sec-edgar","filing":"0001193125-26-393125","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1817838/000119312526393125/ownership.xml","form_type":"4"}},{"id":4619411,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2633,"kind":"person","name":"Lyon Joseph Douglas","position":1,"cik":"0001817838","reported_name":"Lyon Joseph Douglas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-09-16T20:30:08.000Z","date":"2026-09-14","kind":"sale","planned":true,"acquired":false,"shares":2188,"price":114.1163,"value":249686.4644,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was made pursuant to a 10b5-1 plan adopted by the Reporting Person on June 10, 2026 in effect at the time of this transaction."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $113.92 to $114.50 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 178 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025, 398 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 2, 2026, 537 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2026 and 130 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 1, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":5683,"source":{"system":"sec-edgar","filing":"0001193125-26-393125","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1817838/000119312526393125/ownership.xml","form_type":"4"}},{"id":4619410,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2633,"kind":"person","name":"Lyon Joseph Douglas","position":1,"cik":"0001817838","reported_name":"Lyon Joseph Douglas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-09-16T20:30:08.000Z","date":"2026-09-14","kind":"sale","planned":true,"acquired":false,"shares":7812,"price":113.3206,"value":885260.5272,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was made pursuant to a 10b5-1 plan adopted by the Reporting Person on June 10, 2026 in effect at the time of this transaction."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $112.81 to $113.72 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 178 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025, 398 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 2, 2026, 537 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2026 and 130 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 1, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":7871,"source":{"system":"sec-edgar","filing":"0001193125-26-393125","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1817838/000119312526393125/ownership.xml","form_type":"4"}},{"id":4619409,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2633,"kind":"person","name":"Lyon Joseph Douglas","position":1,"cik":"0001817838","reported_name":"Lyon Joseph Douglas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-09-16T20:30:08.000Z","date":"2026-09-14","kind":"exercise","planned":true,"acquired":true,"shares":7404,"price":13.56,"value":100398.24,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 178 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025, 398 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 2, 2026, 537 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2026 and 130 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 1, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":15683,"source":{"system":"sec-edgar","filing":"0001193125-26-393125","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1817838/000119312526393125/ownership.xml","form_type":"4"}},{"id":4619408,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2633,"kind":"person","name":"Lyon Joseph Douglas","position":1,"cik":"0001817838","reported_name":"Lyon Joseph Douglas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-09-16T20:30:08.000Z","date":"2026-09-14","kind":"exercise","planned":true,"acquired":true,"shares":2596,"price":11.35,"value":29464.6,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 178 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025, 398 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 2, 2026, 537 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2026 and 130 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 1, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":8279,"source":{"system":"sec-edgar","filing":"0001193125-26-393125","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1817838/000119312526393125/ownership.xml","form_type":"4"}},{"id":4619416,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":22466,"kind":"person","name":"WILSON JAMES N","position":1,"cik":"0001236387","reported_name":"WILSON JAMES N","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-09-16T20:30:06.000Z","date":"2026-09-15","kind":"sale","planned":true,"acquired":false,"shares":2800,"price":111.7039,"value":312770.92,"ownership":{"direct":false,"nature":"James N. Wilson and Pamela D. Wilson Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was made pursuant to a 10b5-1 plan adopted by the Reporting Person on March 12, 2026 in effect at the time of this transaction."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $111.70 to $111.705 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Reporting Person has voting power over the shares held by the James N. Wilson and Pamela D. Wilson Trust pursuant to voting agreements and disclaims beneficial ownership of all of such shares, except to the extent of his pecuniary interest therein."}],"balance_after":1064543,"source":{"system":"sec-edgar","filing":"0001193125-26-393124","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1236387/000119312526393124/ownership.xml","form_type":"4"}},{"id":4619415,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":22466,"kind":"person","name":"WILSON JAMES N","position":1,"cik":"0001236387","reported_name":"WILSON JAMES N","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-09-16T20:30:06.000Z","date":"2026-09-15","kind":"sale","planned":true,"acquired":false,"shares":400,"price":110.8363,"value":44334.52,"ownership":{"direct":false,"nature":"James N. Wilson and Pamela D. Wilson Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was made pursuant to a 10b5-1 plan adopted by the Reporting Person on March 12, 2026 in effect at the time of this transaction."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $110.665 to $111.095 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Reporting Person has voting power over the shares held by the James N. Wilson and Pamela D. Wilson Trust pursuant to voting agreements and disclaims beneficial ownership of all of such shares, except to the extent of his pecuniary interest therein."}],"balance_after":1067343,"source":{"system":"sec-edgar","filing":"0001193125-26-393124","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1236387/000119312526393124/ownership.xml","form_type":"4"}},{"id":4619414,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":22466,"kind":"person","name":"WILSON JAMES N","position":1,"cik":"0001236387","reported_name":"WILSON JAMES N","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-09-16T20:30:06.000Z","date":"2026-09-15","kind":"sale","planned":true,"acquired":false,"shares":6800,"price":110.2698,"value":749834.64,"ownership":{"direct":false,"nature":"James N. Wilson and Pamela D. Wilson Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was made pursuant to a 10b5-1 plan adopted by the Reporting Person on March 12, 2026 in effect at the time of this transaction."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $109.66 to $110.64 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Reporting Person has voting power over the shares held by the James N. Wilson and Pamela D. Wilson Trust pursuant to voting agreements and disclaims beneficial ownership of all of such shares, except to the extent of his pecuniary interest therein."}],"balance_after":1067743,"source":{"system":"sec-edgar","filing":"0001193125-26-393124","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1236387/000119312526393124/ownership.xml","form_type":"4"}},{"id":4005,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2642,"kind":"person","name":"Guyer William","position":1,"cik":"0001879013","reported_name":"Guyer William","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2026-09-04T01:16:58.000Z","date":"2026-09-01","kind":"grant","planned":false,"acquired":true,"shares":164,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Shares underlie unvested restricted stock awards granted to the Reporting Person by the Issuer under the Purchase Plan. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person remains the beneficial owner of the Purchase Plan Shares through such one-year anniversary."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 224 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025, 498 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 2, 2026 and 877 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":4313,"source":{"system":"sec-edgar","filing":"0001193125-26-382475","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1879013/000119312526382475/ownership.xml","form_type":"4"}},{"id":4004,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2642,"kind":"person","name":"Guyer William","position":1,"cik":"0001879013","reported_name":"Guyer William","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2026-09-04T01:16:58.000Z","date":"2026-09-01","kind":"grant","planned":false,"acquired":true,"shares":164,"price":113.38,"value":18594.32,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person purchased shares (\"Purchase Plan Shares\") of the Issuer's common stock pursuant to a purchase plan (\"Purchase Plan\") established under the Corcept Therapeutics Incorporated 2024 Incentive Award Plan on September 1, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In accordance with the Purchase Plan, the price was established based on the closing price on the day of the purchase."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 224 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025, 498 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 2, 2026 and 877 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":4149,"source":{"system":"sec-edgar","filing":"0001193125-26-382475","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1879013/000119312526382475/ownership.xml","form_type":"4"}},{"id":4002,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2639,"kind":"person","name":"Maduck Sean","position":1,"cik":"0001698310","reported_name":"Maduck Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock option (right to buy)","published_at":"2026-09-04T01:16:42.000Z","date":"2026-09-01","kind":"exercise","planned":true,"acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F17","text":"Fully exercisable."}],"balance_after":66986,"derivative":{"exercise_price":8.27,"expiration_date":"2027-02-10","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001193125-26-382474","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1698310/000119312526382474/ownership.xml","form_type":"4"}},{"id":4001,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2639,"kind":"person","name":"Maduck Sean","position":1,"cik":"0001698310","reported_name":"Maduck Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-09-04T01:16:42.000Z","date":"2026-09-02","kind":"tax_withholding","planned":true,"acquired":false,"shares":117,"price":113.38,"value":13265.46,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F9","text":"These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F10","text":"The closing price on September 1, 2026 was used to calculate the withholding obligation."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F11","text":"Includes 205 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025, 454 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 2, 2026 and 615 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":9938,"source":{"system":"sec-edgar","filing":"0001193125-26-382474","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1698310/000119312526382474/ownership.xml","form_type":"4"}},{"id":4000,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2639,"kind":"person","name":"Maduck Sean","position":1,"cik":"0001698310","reported_name":"Maduck Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-09-04T01:16:42.000Z","date":"2026-09-01","kind":"grant","planned":true,"acquired":true,"shares":150,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F8","text":"Shares underlie unvested restricted stock awards granted to the Reporting Person by the Issuer under the Purchase Plan. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person remains the beneficial owner of the Purchase Plan Shares through such one-year anniversary."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 228 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 2, 2025, 205 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025, 454 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 2, 2026 and 615 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":10055,"source":{"system":"sec-edgar","filing":"0001193125-26-382474","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1698310/000119312526382474/ownership.xml","form_type":"4"}},{"id":3999,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2639,"kind":"person","name":"Maduck Sean","position":1,"cik":"0001698310","reported_name":"Maduck Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-09-04T01:16:42.000Z","date":"2026-09-01","kind":"grant","planned":true,"acquired":true,"shares":150,"price":113.38,"value":17007.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F6","text":"The Reporting Person purchased shares (\"Purchase Plan Shares\") of the Issuer's common stock pursuant to a purchase plan (\"Purchase Plan\") established under the Corcept Therapeutics Incorporated 2024 Incentive Award Plan on September 1, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"In accordance with the Purchase Plan, the price was established based on the closing price on the day of the purchase."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 228 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 2, 2025, 205 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025, 454 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 2, 2026 and 615 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":9905,"source":{"system":"sec-edgar","filing":"0001193125-26-382474","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1698310/000119312526382474/ownership.xml","form_type":"4"}},{"id":3998,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2639,"kind":"person","name":"Maduck Sean","position":1,"cik":"0001698310","reported_name":"Maduck Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-09-04T01:16:42.000Z","date":"2026-09-01","kind":"sale","planned":true,"acquired":false,"shares":2281,"price":115.6118,"value":263710.5158,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was made pursuant to a 10b5-1 plan adopted by the Reporting Person on December 8, 2025 in effect at the time of this transaction."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $115.37 to $115.82 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 228 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 2, 2025, 205 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025, 454 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 2, 2026 and 615 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":9755,"source":{"system":"sec-edgar","filing":"0001193125-26-382474","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1698310/000119312526382474/ownership.xml","form_type":"4"}},{"id":3997,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2639,"kind":"person","name":"Maduck Sean","position":1,"cik":"0001698310","reported_name":"Maduck Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-09-04T01:16:42.000Z","date":"2026-09-01","kind":"sale","planned":true,"acquired":false,"shares":10989,"price":114.7118,"value":1260567.9702,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was made pursuant to a 10b5-1 plan adopted by the Reporting Person on December 8, 2025 in effect at the time of this transaction."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $114.365 to $115.295 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 228 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 2, 2025, 205 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025, 454 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 2, 2026 and 615 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":12036,"source":{"system":"sec-edgar","filing":"0001193125-26-382474","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1698310/000119312526382474/ownership.xml","form_type":"4"}},{"id":3996,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2639,"kind":"person","name":"Maduck Sean","position":1,"cik":"0001698310","reported_name":"Maduck Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-09-04T01:16:42.000Z","date":"2026-09-01","kind":"sale","planned":true,"acquired":false,"shares":11730,"price":113.9351,"value":1336458.723,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was made pursuant to a 10b5-1 plan adopted by the Reporting Person on December 8, 2025 in effect at the time of this transaction."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $113.36 to $114.34 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 228 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 2, 2025, 205 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025, 454 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 2, 2026 and 615 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":23025,"source":{"system":"sec-edgar","filing":"0001193125-26-382474","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1698310/000119312526382474/ownership.xml","form_type":"4"}},{"id":3995,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2639,"kind":"person","name":"Maduck Sean","position":1,"cik":"0001698310","reported_name":"Maduck Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-09-04T01:16:42.000Z","date":"2026-09-01","kind":"exercise","planned":true,"acquired":true,"shares":25000,"price":8.27,"value":206750.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 228 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 2, 2025, 205 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025, 454 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 2, 2026 and 615 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":34755,"source":{"system":"sec-edgar","filing":"0001193125-26-382474","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1698310/000119312526382474/ownership.xml","form_type":"4"}},{"id":3994,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2638,"kind":"person","name":"Mokari Atabak","position":1,"cik":"0001678419","reported_name":"Mokari Atabak","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-09-04T01:06:51.000Z","date":"2026-09-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":102,"price":113.38,"value":11564.76,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The closing price on September 1, 2026 was used to calculate the withholding obligation."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F7","text":"Includes 178 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025, 397 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 2, 2026 and 634 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":16304,"source":{"system":"sec-edgar","filing":"0001193125-26-382463","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1678419/000119312526382463/ownership.xml","form_type":"4"}},{"id":3993,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2638,"kind":"person","name":"Mokari Atabak","position":1,"cik":"0001678419","reported_name":"Mokari Atabak","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-09-04T01:06:51.000Z","date":"2026-09-01","kind":"grant","planned":false,"acquired":true,"shares":138,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Shares underlie unvested restricted stock awards granted to the Reporting Person by the Issuer under the Purchase Plan. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person remains the beneficial owner of the Purchase Plan Shares through such one-year anniversary."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 200 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 2, 2025, 178 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025, 397 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 2, 2026 and 634 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":16406,"source":{"system":"sec-edgar","filing":"0001193125-26-382463","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1678419/000119312526382463/ownership.xml","form_type":"4"}},{"id":3992,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2638,"kind":"person","name":"Mokari Atabak","position":1,"cik":"0001678419","reported_name":"Mokari Atabak","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-09-04T01:06:51.000Z","date":"2026-09-01","kind":"grant","planned":false,"acquired":true,"shares":138,"price":113.38,"value":15646.44,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person purchased shares (\"Purchase Plan Shares\") of the Issuer's common stock pursuant to a purchase plan (\"Purchase Plan\") established under the Corcept Therapeutics Incorporated 2024 Incentive Award Plan on September 1, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In accordance with the Purchase Plan, the price was established based on the closing price on the day of the purchase."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 200 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 2, 2025, 178 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025, 397 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 2, 2026 and 634 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":16268,"source":{"system":"sec-edgar","filing":"0001193125-26-382463","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1678419/000119312526382463/ownership.xml","form_type":"4"}},{"id":3987,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2634,"kind":"person","name":"Robb Gary Charles","position":1,"cik":"0001529655","reported_name":"Robb Gary Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2026-09-04T01:03:08.000Z","date":"2026-09-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":91,"price":113.38,"value":10317.58,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The closing price on September 1, 2026 was used to calculate the withholding obligation."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F7","text":"Includes 224 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025, 499 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 2, 2026 and 776 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":13663,"source":{"system":"sec-edgar","filing":"0001193125-26-382457","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1529655/000119312526382457/ownership.xml","form_type":"4"}},{"id":3986,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2634,"kind":"person","name":"Robb Gary Charles","position":1,"cik":"0001529655","reported_name":"Robb Gary Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2026-09-04T01:03:08.000Z","date":"2026-09-01","kind":"grant","planned":false,"acquired":true,"shares":164,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Shares underlie unvested restricted stock awards granted to the Reporting Person by the Issuer under the Purchase Plan. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person remains the beneficial owner of the Purchase Plan Shares through such one-year anniversary."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 251 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 2, 2025, 224 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025, 499 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 2, 2026 and 776 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":13754,"source":{"system":"sec-edgar","filing":"0001193125-26-382457","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1529655/000119312526382457/ownership.xml","form_type":"4"}},{"id":3985,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2634,"kind":"person","name":"Robb Gary Charles","position":1,"cik":"0001529655","reported_name":"Robb Gary Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2026-09-04T01:03:08.000Z","date":"2026-09-01","kind":"grant","planned":false,"acquired":true,"shares":164,"price":113.38,"value":18594.32,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person purchased shares (\"Purchase Plan Shares\") of the Issuer's common stock pursuant to a purchase plan (\"Purchase Plan\") established under the Corcept Therapeutics Incorporated 2024 Incentive Award Plan on September 1, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In accordance with the Purchase Plan, the price was established based on the closing price on the day of the purchase."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 251 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 2, 2025, 224 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025, 499 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 2, 2026 and 776 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":13590,"source":{"system":"sec-edgar","filing":"0001193125-26-382457","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1529655/000119312526382457/ownership.xml","form_type":"4"}},{"id":3984,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2621,"kind":"person","name":"Vieira Roberto Wandenkolk","position":1,"cik":"0002150104","reported_name":"Vieira Roberto Wandenkolk","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Oncology"}}],"security":"Stock option (right to buy)","published_at":"2026-09-04T01:02:52.000Z","date":"2026-09-02","kind":"exercise","planned":true,"acquired":false,"shares":58333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F16","text":"Shares subject to the stock option vested and became exercisable with respect to 25% of the shares underlying the option on January 29, 2025 with the remaining shares vesting and becoming exercisable ratably on a monthly basis over a period of 36 consecutive months thereafter until fully vested and exercisable on January 29, 2028, subject to the Reporting Person's continued service."}],"balance_after":141667,"derivative":{"exercise_price":21.63,"expiration_date":"2034-02-01","underlying":"Common Stock","underlying_shares":58333},"source":{"system":"sec-edgar","filing":"0001193125-26-382456","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/2150104/000119312526382456/ownership.xml","form_type":"4"}},{"id":3983,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2621,"kind":"person","name":"Vieira Roberto Wandenkolk","position":1,"cik":"0002150104","reported_name":"Vieira Roberto Wandenkolk","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Oncology"}}],"security":"Common Stock","published_at":"2026-09-04T01:02:52.000Z","date":"2026-09-02","kind":"sale","planned":true,"acquired":false,"shares":1225,"price":115.4395,"value":141413.3875,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F8","text":"This transaction was made pursuant to a 10b5-1 plan adopted by the Reporting Person on June 17, 2026, prior to the reporting person being appointed an officer of the Issuer, which was in effect at the time of this transaction."},{"field":"price","element":"transactionPricePerShare","label":"F15","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $115.255 to $115.57 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F7","text":"Includes 179 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025, 396 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 2, 2026 and 634 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":4242,"source":{"system":"sec-edgar","filing":"0001193125-26-382456","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/2150104/000119312526382456/ownership.xml","form_type":"4"}},{"id":3982,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2621,"kind":"person","name":"Vieira Roberto Wandenkolk","position":1,"cik":"0002150104","reported_name":"Vieira Roberto Wandenkolk","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Oncology"}}],"security":"Common Stock","published_at":"2026-09-04T01:02:52.000Z","date":"2026-09-02","kind":"sale","planned":true,"acquired":false,"shares":5621,"price":114.5779,"value":644042.3759,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F8","text":"This transaction was made pursuant to a 10b5-1 plan adopted by the Reporting Person on June 17, 2026, prior to the reporting person being appointed an officer of the Issuer, which was in effect at the time of this transaction."},{"field":"price","element":"transactionPricePerShare","label":"F14","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $114.24 to $115.195 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F7","text":"Includes 179 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025, 396 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 2, 2026 and 634 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":5467,"source":{"system":"sec-edgar","filing":"0001193125-26-382456","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/2150104/000119312526382456/ownership.xml","form_type":"4"}},{"id":3981,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2621,"kind":"person","name":"Vieira Roberto Wandenkolk","position":1,"cik":"0002150104","reported_name":"Vieira Roberto Wandenkolk","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Oncology"}}],"security":"Common Stock","published_at":"2026-09-04T01:02:52.000Z","date":"2026-09-02","kind":"sale","planned":true,"acquired":false,"shares":1606,"price":113.7187,"value":182632.2322,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F8","text":"This transaction was made pursuant to a 10b5-1 plan adopted by the Reporting Person on June 17, 2026, prior to the reporting person being appointed an officer of the Issuer, which was in effect at the time of this transaction."},{"field":"price","element":"transactionPricePerShare","label":"F13","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $113.11 to $114.09 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F7","text":"Includes 179 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025, 396 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 2, 2026 and 634 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":11088,"source":{"system":"sec-edgar","filing":"0001193125-26-382456","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/2150104/000119312526382456/ownership.xml","form_type":"4"}},{"id":3980,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2621,"kind":"person","name":"Vieira Roberto Wandenkolk","position":1,"cik":"0002150104","reported_name":"Vieira Roberto Wandenkolk","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Oncology"}}],"security":"Common Stock","published_at":"2026-09-04T01:02:52.000Z","date":"2026-09-02","kind":"sale","planned":true,"acquired":false,"shares":974,"price":112.3966,"value":109474.2884,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F8","text":"This transaction was made pursuant to a 10b5-1 plan adopted by the Reporting Person on June 17, 2026, prior to the reporting person being appointed an officer of the Issuer, which was in effect at the time of this transaction."},{"field":"price","element":"transactionPricePerShare","label":"F12","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $112.08 to $113.03 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F7","text":"Includes 179 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025, 396 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 2, 2026 and 634 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":12694,"source":{"system":"sec-edgar","filing":"0001193125-26-382456","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/2150104/000119312526382456/ownership.xml","form_type":"4"}},{"id":3979,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2621,"kind":"person","name":"Vieira Roberto Wandenkolk","position":1,"cik":"0002150104","reported_name":"Vieira Roberto Wandenkolk","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Oncology"}}],"security":"Common Stock","published_at":"2026-09-04T01:02:52.000Z","date":"2026-09-02","kind":"sale","planned":true,"acquired":false,"shares":1537,"price":111.3733,"value":171180.7621,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F8","text":"This transaction was made pursuant to a 10b5-1 plan adopted by the Reporting Person on June 17, 2026, prior to the reporting person being appointed an officer of the Issuer, which was in effect at the time of this transaction."},{"field":"price","element":"transactionPricePerShare","label":"F11","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $111.06 to $111.945 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F7","text":"Includes 179 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025, 396 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 2, 2026 and 634 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":13668,"source":{"system":"sec-edgar","filing":"0001193125-26-382456","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/2150104/000119312526382456/ownership.xml","form_type":"4"}},{"id":3978,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2621,"kind":"person","name":"Vieira Roberto Wandenkolk","position":1,"cik":"0002150104","reported_name":"Vieira Roberto Wandenkolk","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Oncology"}}],"security":"Common Stock","published_at":"2026-09-04T01:02:52.000Z","date":"2026-09-02","kind":"sale","planned":true,"acquired":false,"shares":23770,"price":110.7004,"value":2631348.508,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F8","text":"This transaction was made pursuant to a 10b5-1 plan adopted by the Reporting Person on June 17, 2026, prior to the reporting person being appointed an officer of the Issuer, which was in effect at the time of this transaction."},{"field":"price","element":"transactionPricePerShare","label":"F10","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $110.06 to $111.03 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F7","text":"Includes 179 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025, 396 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 2, 2026 and 634 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":15205,"source":{"system":"sec-edgar","filing":"0001193125-26-382456","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/2150104/000119312526382456/ownership.xml","form_type":"4"}},{"id":3977,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2621,"kind":"person","name":"Vieira Roberto Wandenkolk","position":1,"cik":"0002150104","reported_name":"Vieira Roberto Wandenkolk","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Oncology"}}],"security":"Common Stock","published_at":"2026-09-04T01:02:52.000Z","date":"2026-09-02","kind":"sale","planned":true,"acquired":false,"shares":23600,"price":109.3506,"value":2580674.16,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F8","text":"This transaction was made pursuant to a 10b5-1 plan adopted by the Reporting Person on June 17, 2026, prior to the reporting person being appointed an officer of the Issuer, which was in effect at the time of this transaction."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $108.97 to $109.83 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F7","text":"Includes 179 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025, 396 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 2, 2026 and 634 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":38975,"source":{"system":"sec-edgar","filing":"0001193125-26-382456","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/2150104/000119312526382456/ownership.xml","form_type":"4"}},{"id":3976,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2621,"kind":"person","name":"Vieira Roberto Wandenkolk","position":1,"cik":"0002150104","reported_name":"Vieira Roberto Wandenkolk","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Oncology"}}],"security":"Common Stock","published_at":"2026-09-04T01:02:52.000Z","date":"2026-09-02","kind":"exercise","planned":true,"acquired":true,"shares":58333,"price":21.63,"value":1261742.79,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F7","text":"Includes 179 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025, 396 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 2, 2026 and 634 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":62575,"source":{"system":"sec-edgar","filing":"0001193125-26-382456","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/2150104/000119312526382456/ownership.xml","form_type":"4"}},{"id":3975,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2621,"kind":"person","name":"Vieira Roberto Wandenkolk","position":1,"cik":"0002150104","reported_name":"Vieira Roberto Wandenkolk","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Oncology"}}],"security":"Common Stock","published_at":"2026-09-04T01:02:52.000Z","date":"2026-09-02","kind":"tax_withholding","planned":true,"acquired":false,"shares":102,"price":113.38,"value":11564.76,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The closing price on September 1, 2026 was used to calculate the withholding obligation."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F7","text":"Includes 179 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025, 396 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 2, 2026 and 634 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":4242,"source":{"system":"sec-edgar","filing":"0001193125-26-382456","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2150104/000119312526382456/ownership.xml","form_type":"4"}},{"id":3974,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2621,"kind":"person","name":"Vieira Roberto Wandenkolk","position":1,"cik":"0002150104","reported_name":"Vieira Roberto Wandenkolk","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Oncology"}}],"security":"Common Stock","published_at":"2026-09-04T01:02:52.000Z","date":"2026-09-01","kind":"grant","planned":true,"acquired":true,"shares":138,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Shares underlie unvested restricted stock awards granted to the Reporting Person by the Issuer under the Purchase Plan. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person remains the beneficial owner of the Purchase Plan Shares through such one-year anniversary."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 199 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 2, 2025, 179 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025, 396 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 2, 2026 and 634 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":4344,"source":{"system":"sec-edgar","filing":"0001193125-26-382456","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2150104/000119312526382456/ownership.xml","form_type":"4"}},{"id":3973,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2621,"kind":"person","name":"Vieira Roberto Wandenkolk","position":1,"cik":"0002150104","reported_name":"Vieira Roberto Wandenkolk","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, Oncology"}}],"security":"Common Stock","published_at":"2026-09-04T01:02:52.000Z","date":"2026-09-01","kind":"grant","planned":true,"acquired":true,"shares":138,"price":113.38,"value":15646.44,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person purchased shares (\"Purchase Plan Shares\") of the Issuer's common stock pursuant to a purchase plan (\"Purchase Plan\") established under the Corcept Therapeutics Incorporated 2024 Incentive Award Plan on September 1, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In accordance with the Purchase Plan, the price was established based on the closing price on the day of the purchase."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 199 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 2, 2025, 179 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025, 396 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 2, 2026 and 634 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":4206,"source":{"system":"sec-edgar","filing":"0001193125-26-382456","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2150104/000119312526382456/ownership.xml","form_type":"4"}},{"id":3972,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2633,"kind":"person","name":"Lyon Joseph Douglas","position":1,"cik":"0001817838","reported_name":"Lyon Joseph Douglas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-09-04T01:00:46.000Z","date":"2026-09-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":72,"price":113.38,"value":8163.36,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The closing price on September 1, 2026 was used to calculate the withholding obligation."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F7","text":"Includes 178 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025, 398 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 2, 2026 and 537 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":5683,"source":{"system":"sec-edgar","filing":"0001193125-26-382450","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1817838/000119312526382450/ownership.xml","form_type":"4"}},{"id":3971,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2633,"kind":"person","name":"Lyon Joseph Douglas","position":1,"cik":"0001817838","reported_name":"Lyon Joseph Douglas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-09-04T01:00:46.000Z","date":"2026-09-01","kind":"grant","planned":false,"acquired":true,"shares":130,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Shares underlie unvested restricted stock awards granted to the Reporting Person by the Issuer under the Purchase Plan. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person remains the beneficial owner of the Purchase Plan Shares through such one-year anniversary."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 200 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 2, 2025, 178 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025, 398 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 2, 2026 and 537 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":5755,"source":{"system":"sec-edgar","filing":"0001193125-26-382450","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1817838/000119312526382450/ownership.xml","form_type":"4"}},{"id":3970,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2633,"kind":"person","name":"Lyon Joseph Douglas","position":1,"cik":"0001817838","reported_name":"Lyon Joseph Douglas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-09-04T01:00:46.000Z","date":"2026-09-01","kind":"grant","planned":false,"acquired":true,"shares":130,"price":113.38,"value":14739.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person purchased shares (\"Purchase Plan Shares\") of the Issuer's common stock pursuant to a purchase plan (\"Purchase Plan\") established under the Corcept Therapeutics Incorporated 2024 Incentive Award Plan on September 1, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In accordance with the Purchase Plan, the price was established based on the closing price on the day of the purchase."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 200 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 2, 2025, 178 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025, 398 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 2, 2026 and 537 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":5625,"source":{"system":"sec-edgar","filing":"0001193125-26-382450","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1817838/000119312526382450/ownership.xml","form_type":"4"}},{"id":673275,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":18840,"kind":"person","name":"Park Kimberly","position":1,"cik":"0001788208","reported_name":"Park Kimberly","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-08-28T20:30:05.000Z","date":"2026-08-26","kind":"exercise","planned":false,"acquired":false,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Fully exercisable."}],"balance_after":30000,"derivative":{"exercise_price":13.49,"expiration_date":"2029-09-17","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001193125-26-374607","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312526374607/ownership.xml","form_type":"4"}},{"id":673274,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":18840,"kind":"person","name":"Park Kimberly","position":1,"cik":"0001788208","reported_name":"Park Kimberly","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-08-28T20:30:05.000Z","date":"2026-08-26","kind":"sale","planned":false,"acquired":false,"shares":26685,"price":122.5471,"value":3270169.3635,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $122.50 to $122.80 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001193125-26-374607","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312526374607/ownership.xml","form_type":"4"}},{"id":673273,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":18840,"kind":"person","name":"Park Kimberly","position":1,"cik":"0001788208","reported_name":"Park Kimberly","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-08-28T20:30:05.000Z","date":"2026-08-26","kind":"tax_withholding","planned":false,"acquired":false,"shares":3315,"price":122.09,"value":404728.35,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares were withheld by the Issuer in order to cover the exercise price in connection with the net exercise of stock options reported herein."}],"balance_after":26685,"source":{"system":"sec-edgar","filing":"0001193125-26-374607","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312526374607/ownership.xml","form_type":"4"}},{"id":673272,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":18840,"kind":"person","name":"Park Kimberly","position":1,"cik":"0001788208","reported_name":"Park Kimberly","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-08-28T20:30:05.000Z","date":"2026-08-26","kind":"exercise","planned":false,"acquired":true,"shares":30000,"price":13.49,"value":404700.0,"ownership":{"direct":true},"balance_after":30000,"source":{"system":"sec-edgar","filing":"0001193125-26-374607","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312526374607/ownership.xml","form_type":"4"}},{"id":674157,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2639,"kind":"person","name":"Maduck Sean","position":1,"cik":"0001698310","reported_name":"Maduck Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock option (right to buy)","published_at":"2026-08-27T20:30:04.000Z","date":"2026-08-25","kind":"exercise","planned":true,"acquired":false,"shares":30955,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"Fully exercisable."}],"balance_after":169045,"derivative":{"exercise_price":11.35,"expiration_date":"2029-02-08","underlying":"Common Stock","underlying_shares":30955},"source":{"system":"sec-edgar","filing":"0001193125-26-371388","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312526371388/ownership.xml","form_type":"4"}},{"id":674156,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2639,"kind":"person","name":"Maduck Sean","position":1,"cik":"0001698310","reported_name":"Maduck Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-08-27T20:30:04.000Z","date":"2026-08-25","kind":"sale","planned":true,"acquired":false,"shares":5870,"price":126.0588,"value":739965.156,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was made pursuant to a 10b5-1 plan adopted by the Reporting Person on December 8, 2025 in effect at the time of this transaction."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $126.00 to $126.23 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 228 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 2, 2025, 205 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025, 454 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 2, 2026 and 615 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":9755,"source":{"system":"sec-edgar","filing":"0001193125-26-371388","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312526371388/ownership.xml","form_type":"4"}},{"id":674155,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2639,"kind":"person","name":"Maduck Sean","position":1,"cik":"0001698310","reported_name":"Maduck Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-08-27T20:30:04.000Z","date":"2026-08-25","kind":"sale","planned":true,"acquired":false,"shares":25085,"price":125.4676,"value":3147354.746,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was made pursuant to a 10b5-1 plan adopted by the Reporting Person on December 8, 2025 in effect at the time of this transaction."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $125.00 to $125.98 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 228 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 2, 2025, 205 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025, 454 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 2, 2026 and 615 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":15625,"source":{"system":"sec-edgar","filing":"0001193125-26-371388","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312526371388/ownership.xml","form_type":"4"}},{"id":674154,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2639,"kind":"person","name":"Maduck Sean","position":1,"cik":"0001698310","reported_name":"Maduck Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-08-27T20:30:04.000Z","date":"2026-08-25","kind":"exercise","planned":true,"acquired":true,"shares":30955,"price":11.35,"value":351339.25,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 228 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 2, 2025, 205 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025, 454 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 2, 2026 and 615 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":40710,"source":{"system":"sec-edgar","filing":"0001193125-26-371388","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312526371388/ownership.xml","form_type":"4"}},{"id":680441,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":21365,"kind":"person","name":"MAHONEY DAVID L","position":1,"cik":"0001224091","reported_name":"MAHONEY DAVID L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-08-20T20:30:08.000Z","date":"2026-08-18","kind":"sale","planned":true,"acquired":false,"shares":400,"price":119.6381,"value":47855.24,"ownership":{"direct":false,"nature":"Held by David L. Mahoney and Winnifred C. Ellis 1998 Family Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was made pursuant to a 10b5-1 plan adopted by the Reporting Person on May 11, 2026 in effect at the time of this transaction."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $119.605 to $119.6775. Information on the exact number of shares sold at each sale price can be obtained from the issuer upon request."}],"balance_after":1133539,"source":{"system":"sec-edgar","filing":"0001193125-26-359255","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312526359255/ownership.xml","form_type":"4"}},{"id":680440,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":21365,"kind":"person","name":"MAHONEY DAVID L","position":1,"cik":"0001224091","reported_name":"MAHONEY DAVID L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-08-20T20:30:08.000Z","date":"2026-08-18","kind":"sale","planned":true,"acquired":false,"shares":7055,"price":118.8817,"value":838710.3935,"ownership":{"direct":false,"nature":"Held by David L. Mahoney and Winnifred C. Ellis 1998 Family Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was made pursuant to a 10b5-1 plan adopted by the Reporting Person on May 11, 2026 in effect at the time of this transaction."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $118.60 to $119.345. Information on the exact number of shares sold at each sale price can be obtained from the issuer upon request."}],"balance_after":1133939,"source":{"system":"sec-edgar","filing":"0001193125-26-359255","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312526359255/ownership.xml","form_type":"4"}},{"id":680439,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":21365,"kind":"person","name":"MAHONEY DAVID L","position":1,"cik":"0001224091","reported_name":"MAHONEY DAVID L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-08-20T20:30:08.000Z","date":"2026-08-18","kind":"sale","planned":true,"acquired":false,"shares":91167,"price":118.2376,"value":10779367.2792,"ownership":{"direct":false,"nature":"Held by David L. Mahoney and Winnifred C. Ellis 1998 Family Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was made pursuant to a 10b5-1 plan adopted by the Reporting Person on May 11, 2026 in effect at the time of this transaction."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $117.60 to $118.595. Information on the exact number of shares sold at each sale price can be obtained from the issuer upon request."}],"balance_after":1140994,"source":{"system":"sec-edgar","filing":"0001193125-26-359255","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312526359255/ownership.xml","form_type":"4"}},{"id":680438,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":21365,"kind":"person","name":"MAHONEY DAVID L","position":1,"cik":"0001224091","reported_name":"MAHONEY DAVID L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-08-20T20:30:08.000Z","date":"2026-08-18","kind":"sale","planned":true,"acquired":false,"shares":4984,"price":117.4716,"value":585478.4544,"ownership":{"direct":false,"nature":"Held by David L. Mahoney and Winnifred C. Ellis 1998 Family Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was made pursuant to a 10b5-1 plan adopted by the Reporting Person on May 11, 2026 in effect at the time of this transaction."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $116.595 to $117.59. Information on the exact number of shares sold at each sale price can be obtained from the issuer upon request."}],"balance_after":1232161,"source":{"system":"sec-edgar","filing":"0001193125-26-359255","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312526359255/ownership.xml","form_type":"4"}},{"id":684295,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2639,"kind":"person","name":"Maduck Sean","position":1,"cik":"0001698310","reported_name":"Maduck Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock option (right to buy)","published_at":"2026-08-18T20:30:11.000Z","date":"2026-08-14","kind":"exercise","planned":true,"acquired":false,"shares":3664,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"Fully exercisable."}],"balance_after":91986,"derivative":{"exercise_price":8.27,"expiration_date":"2027-02-10","underlying":"Common Stock","underlying_shares":3664},"source":{"system":"sec-edgar","filing":"0001193125-26-355563","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312526355563/ownership.xml","form_type":"4"}},{"id":684294,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2639,"kind":"person","name":"Maduck Sean","position":1,"cik":"0001698310","reported_name":"Maduck Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-08-18T20:30:11.000Z","date":"2026-08-14","kind":"sale","planned":true,"acquired":false,"shares":3664,"price":114.49,"value":419491.36,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was made pursuant to a 10b5-1 plan adopted by the Reporting Person on December 8, 2025 in effect at the time of this transaction."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 228 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 2, 2025, 205 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025, 454 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 2, 2026 and 615 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":9755,"source":{"system":"sec-edgar","filing":"0001193125-26-355563","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312526355563/ownership.xml","form_type":"4"}},{"id":684293,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2639,"kind":"person","name":"Maduck Sean","position":1,"cik":"0001698310","reported_name":"Maduck Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-08-18T20:30:11.000Z","date":"2026-08-14","kind":"exercise","planned":true,"acquired":true,"shares":3664,"price":8.27,"value":30301.28,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 228 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 2, 2025, 205 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025, 454 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 2, 2026 and 615 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":13419,"source":{"system":"sec-edgar","filing":"0001193125-26-355563","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312526355563/ownership.xml","form_type":"4"}},{"id":684292,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":22466,"kind":"person","name":"WILSON JAMES N","position":1,"cik":"0001236387","reported_name":"WILSON JAMES N","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-08-18T20:30:09.000Z","date":"2026-08-14","kind":"sale","planned":true,"acquired":false,"shares":2279,"price":112.6398,"value":256706.1042,"ownership":{"direct":false,"nature":"James N. Wilson and Pamela D. Wilson Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was made pursuant to a 10b5-1 plan adopted by the Reporting Person on March 12, 2026 in effect at the time of this transaction."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $112.51 to $112.83 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Reporting Person has voting power over the shares held by the James N. Wilson and Pamela D. Wilson Trust pursuant to voting agreements and disclaims beneficial ownership of all of such shares, except to the extent of his pecuniary interest therein."}],"balance_after":1074543,"source":{"system":"sec-edgar","filing":"0001193125-26-355562","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312526355562/ownership.xml","form_type":"4"}},{"id":684291,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":22466,"kind":"person","name":"WILSON JAMES N","position":1,"cik":"0001236387","reported_name":"WILSON JAMES N","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-08-18T20:30:09.000Z","date":"2026-08-14","kind":"sale","planned":true,"acquired":false,"shares":4668,"price":111.4425,"value":520213.59,"ownership":{"direct":false,"nature":"James N. Wilson and Pamela D. Wilson Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was made pursuant to a 10b5-1 plan adopted by the Reporting Person on March 12, 2026 in effect at the time of this transaction."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $111.01 to $112.00 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Reporting Person has voting power over the shares held by the James N. Wilson and Pamela D. Wilson Trust pursuant to voting agreements and disclaims beneficial ownership of all of such shares, except to the extent of his pecuniary interest therein."}],"balance_after":1076822,"source":{"system":"sec-edgar","filing":"0001193125-26-355562","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312526355562/ownership.xml","form_type":"4"}},{"id":684290,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":22466,"kind":"person","name":"WILSON JAMES N","position":1,"cik":"0001236387","reported_name":"WILSON JAMES N","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-08-18T20:30:09.000Z","date":"2026-08-14","kind":"sale","planned":true,"acquired":false,"shares":3053,"price":110.4949,"value":337340.9297,"ownership":{"direct":false,"nature":"James N. Wilson and Pamela D. Wilson Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was made pursuant to a 10b5-1 plan adopted by the Reporting Person on March 12, 2026 in effect at the time of this transaction."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $110.00 to $110.98 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Reporting Person has voting power over the shares held by the James N. Wilson and Pamela D. Wilson Trust pursuant to voting agreements and disclaims beneficial ownership of all of such shares, except to the extent of his pecuniary interest therein."}],"balance_after":1081490,"source":{"system":"sec-edgar","filing":"0001193125-26-355562","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312526355562/ownership.xml","form_type":"4"}},{"id":684289,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2634,"kind":"person","name":"Robb Gary Charles","position":1,"cik":"0001529655","reported_name":"Robb Gary Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2026-08-18T20:30:06.000Z","date":"2026-08-17","kind":"sale","planned":false,"acquired":false,"shares":10000,"price":116.2572,"value":1162572.0,"ownership":{"direct":false,"nature":"Gary Charles Robb TTE Robb Revocable Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $116.00 to $116.54 per share. Information on the exact number of shares sold at each sale price can be obtained from the issuer upon request."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These shares are held by Gary Charles Robb TTE Robb Revocable Trust of which the Reporting Person is trustee."}],"balance_after":39716,"source":{"system":"sec-edgar","filing":"0001193125-26-355560","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312526355560/ownership.xml","form_type":"4"}},{"id":684288,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2634,"kind":"person","name":"Robb Gary Charles","position":1,"cik":"0001529655","reported_name":"Robb Gary Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2026-08-18T20:30:06.000Z","date":"2026-08-17","kind":"gift","planned":false,"acquired":false,"shares":125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 251 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 2, 2025, 224 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025, 499 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 2, 2026 and 776 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":13426,"source":{"system":"sec-edgar","filing":"0001193125-26-355560","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312526355560/ownership.xml","form_type":"4"}},{"id":687276,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2634,"kind":"person","name":"Robb Gary Charles","position":1,"cik":"0001529655","reported_name":"Robb Gary Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2026-08-14T20:31:37.000Z","date":"2026-08-12","kind":"gift","planned":false,"acquired":true,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Custodial Account for Child"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These shares are held by a child of the Reporting Person through a custodial account under the Uniform Transfers to Minors Act for which the Reporting Person is custodian."}],"balance_after":15571,"source":{"system":"sec-edgar","filing":"0001193125-26-352428","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312526352428/ownership.xml","form_type":"4"}},{"id":687275,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2634,"kind":"person","name":"Robb Gary Charles","position":1,"cik":"0001529655","reported_name":"Robb Gary Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2026-08-14T20:31:37.000Z","date":"2026-08-12","kind":"gift","planned":false,"acquired":true,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Custodial Account for Child"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held by a child of the Reporting Person through a custodial account under the Uniform Transfers to Minors Act for which the Reporting Person is custodian."}],"balance_after":15571,"source":{"system":"sec-edgar","filing":"0001193125-26-352428","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312526352428/ownership.xml","form_type":"4"}},{"id":687274,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2634,"kind":"person","name":"Robb Gary Charles","position":1,"cik":"0001529655","reported_name":"Robb Gary Charles","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2026-08-14T20:31:37.000Z","date":"2026-08-12","kind":"gift","planned":false,"acquired":false,"shares":11530,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 251 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 2, 2025, 224 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025, 499 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 2, 2026 and 776 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":13551,"source":{"system":"sec-edgar","filing":"0001193125-26-352428","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312526352428/ownership.xml","form_type":"4"}},{"id":689783,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2639,"kind":"person","name":"Maduck Sean","position":1,"cik":"0001698310","reported_name":"Maduck Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock option (right to buy)","published_at":"2026-08-12T20:27:23.000Z","date":"2026-08-10","kind":"exercise","planned":true,"acquired":false,"shares":1031,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"Fully exercisable."}],"balance_after":95650,"derivative":{"exercise_price":8.27,"expiration_date":"2027-02-10","underlying":"Common Stock","underlying_shares":1031},"source":{"system":"sec-edgar","filing":"0001193125-26-346951","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312526346951/ownership.xml","form_type":"4"}},{"id":689782,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2639,"kind":"person","name":"Maduck Sean","position":1,"cik":"0001698310","reported_name":"Maduck Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-08-12T20:27:23.000Z","date":"2026-08-10","kind":"sale","planned":true,"acquired":false,"shares":1031,"price":114.5182,"value":118068.2642,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was made pursuant to a 10b5-1 plan adopted by the Reporting Person on December 8, 2025 in effect at the time of this transaction."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $114.50 to $114.58 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 228 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 2, 2025, 205 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025, 454 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 2, 2026 and 615 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":9755,"source":{"system":"sec-edgar","filing":"0001193125-26-346951","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312526346951/ownership.xml","form_type":"4"}},{"id":689781,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2639,"kind":"person","name":"Maduck Sean","position":1,"cik":"0001698310","reported_name":"Maduck Sean","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-08-12T20:27:23.000Z","date":"2026-08-10","kind":"exercise","planned":true,"acquired":true,"shares":1031,"price":8.27,"value":8526.37,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 228 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 2, 2025, 205 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025, 454 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 2, 2026 and 615 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":10786,"source":{"system":"sec-edgar","filing":"0001193125-26-346951","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312526346951/ownership.xml","form_type":"4"}},{"id":689780,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2642,"kind":"person","name":"Guyer William","position":1,"cik":"0001879013","reported_name":"Guyer William","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Stock Option (right to buy)","published_at":"2026-08-12T20:26:08.000Z","date":"2026-08-10","kind":"exercise","planned":true,"acquired":false,"shares":16300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Fully exercisable."}],"balance_after":110000,"derivative":{"exercise_price":21.65,"expiration_date":"2031-09-01","underlying":"Common Stock","underlying_shares":16300},"source":{"system":"sec-edgar","filing":"0001193125-26-346942","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312526346942/ownership.xml","form_type":"4"}},{"id":689779,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2642,"kind":"person","name":"Guyer William","position":1,"cik":"0001879013","reported_name":"Guyer William","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2026-08-12T20:26:08.000Z","date":"2026-08-10","kind":"sale","planned":true,"acquired":false,"shares":4770,"price":114.0371,"value":543956.967,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was made pursuant to a 10b5-1 plan adopted by the Reporting Person on November 27, 2024 in effect at the time of this transaction."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $113.98 to $114.24 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 224 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025, 498 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 2, 2026 and 877 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":3985,"source":{"system":"sec-edgar","filing":"0001193125-26-346942","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312526346942/ownership.xml","form_type":"4"}},{"id":689778,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2642,"kind":"person","name":"Guyer William","position":1,"cik":"0001879013","reported_name":"Guyer William","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2026-08-12T20:26:08.000Z","date":"2026-08-10","kind":"sale","planned":true,"acquired":false,"shares":11530,"price":113.1772,"value":1304933.116,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was made pursuant to a 10b5-1 plan adopted by the Reporting Person on November 27, 2024 in effect at the time of this transaction."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $112.80 to $113.75 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 224 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025, 498 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 2, 2026 and 877 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":8755,"source":{"system":"sec-edgar","filing":"0001193125-26-346942","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312526346942/ownership.xml","form_type":"4"}},{"id":689777,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2642,"kind":"person","name":"Guyer William","position":1,"cik":"0001879013","reported_name":"Guyer William","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2026-08-12T20:26:08.000Z","date":"2026-08-10","kind":"exercise","planned":true,"acquired":true,"shares":16300,"price":21.65,"value":352895.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 224 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025, 498 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 2, 2026 and 877 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":20285,"source":{"system":"sec-edgar","filing":"0001193125-26-346942","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312526346942/ownership.xml","form_type":"4"}},{"id":694597,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2642,"kind":"person","name":"Guyer William","position":1,"cik":"0001879013","reported_name":"Guyer William","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Stock Option (right to buy)","published_at":"2026-08-06T22:44:47.000Z","date":"2026-08-04","kind":"exercise","planned":true,"acquired":false,"shares":3700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Fully exercisable."}],"balance_after":126300,"derivative":{"exercise_price":21.65,"expiration_date":"2031-09-01","underlying":"Common Stock","underlying_shares":3700},"source":{"system":"sec-edgar","filing":"0001193125-26-338637","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312526338637/ownership.xml","form_type":"4"}},{"id":694596,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2642,"kind":"person","name":"Guyer William","position":1,"cik":"0001879013","reported_name":"Guyer William","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2026-08-06T22:44:47.000Z","date":"2026-08-04","kind":"sale","planned":true,"acquired":false,"shares":3700,"price":113.1248,"value":418561.76,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction was made pursuant to a 10b5-1 plan adopted by the Reporting Person on November 27, 2024 in effect at the time of this transaction."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $112.92 to $113.455 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 224 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025, 498 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 2, 2026 and 877 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":3985,"source":{"system":"sec-edgar","filing":"0001193125-26-338637","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312526338637/ownership.xml","form_type":"4"}},{"id":694595,"issuer":{"id":2620,"kind":"organization","name":"CORCEPT THERAPEUTICS INC","symbol":"CORT"},"owners":[{"id":2642,"kind":"person","name":"Guyer William","position":1,"cik":"0001879013","reported_name":"Guyer William","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Common Stock","published_at":"2026-08-06T22:44:47.000Z","date":"2026-08-04","kind":"exercise","planned":true,"acquired":true,"shares":3700,"price":21.65,"value":80105.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 224 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025, 498 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 2, 2026 and 877 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements."}],"balance_after":7685,"source":{"system":"sec-edgar","filing":"0001193125-26-338637","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1088856/000119312526338637/ownership.xml","form_type":"4"}}],"next_cursor":"2026-08-06T22:44:47.000000Z,694595"}